These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 972284

  • 21. Efficacy and safety of cefamandole plus either gentamicin or tobramycin in therapy of severe gram-negative bacterial infections.
    Gentry LO.
    J Infect Dis; 1978 May; 137 Suppl():S144-S149. PubMed ID: 349093
    [Abstract] [Full Text] [Related]

  • 22. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M.
    Med Klin; 1978 Jun 16; 73(24):914-7. PubMed ID: 661734
    [Abstract] [Full Text] [Related]

  • 23. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C, Crevatin E.
    Ann Sclavo; 1977 Jun 16; 19(3):437-45. PubMed ID: 415672
    [Abstract] [Full Text] [Related]

  • 24. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K, Midtvedt T, Dahl O.
    Chemotherapy; 1979 Jun 16; 25(5):286-95. PubMed ID: 113179
    [Abstract] [Full Text] [Related]

  • 25. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M, Brun Y, Forey F, Fleurette J.
    Nouv Presse Med; 1982 Nov 18; 11(46):3391-5. PubMed ID: 7155846
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance.
    Cross AS, Opal S, Kopecko DJ.
    Arch Intern Med; 1983 Nov 18; 143(11):2075-80. PubMed ID: 6639227
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
    Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS.
    Drugs; 1976 Nov 18; 12(3):166-200. PubMed ID: 789045
    [Abstract] [Full Text] [Related]

  • 30. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL, Alvarez S, Ortega G, Verghese A, Holtsclaw-Berk SA.
    Arch Intern Med; 1986 Mar 18; 146(3):538-41. PubMed ID: 3954526
    [Abstract] [Full Text] [Related]

  • 31. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms.
    Yu VL, Rhame FS, Pesanti EL, Axline SG.
    JAMA; 1977 Aug 29; 238(9):943-7. PubMed ID: 328950
    [Abstract] [Full Text] [Related]

  • 32. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR, Krafczyk TL.
    Chemotherapy; 1980 Aug 29; 26(5):323-33. PubMed ID: 7389428
    [Abstract] [Full Text] [Related]

  • 33. A clinical comparison of tobramycin and gentamicin sulfate in the treatment of ocular infections.
    Laibson P, Michaud R, Smolin G, Okumoto M, Rosenthal A, Cagle G.
    Am J Ophthalmol; 1981 Dec 29; 92(6):836-41. PubMed ID: 7032304
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.
    Gentry LO, Wood BA, Martin MD, Smythe J.
    Scand J Infect Dis Suppl; 1980 Dec 29; suppl 25():96-100. PubMed ID: 7010544
    [Abstract] [Full Text] [Related]

  • 36. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L, Robinson RG, Koornhof HJ.
    S Afr Med J; 1984 Jun 09; 65(23):922-4. PubMed ID: 6427946
    [Abstract] [Full Text] [Related]

  • 37. Cross infection in a surgical ward caused by Pseudomonas aeruginosa with transferable resistance to gentamicin and tobramycin.
    Falkiner FR, Keane CT, Dalton M, Clancy MT, Jacoby GA.
    J Clin Pathol; 1977 Aug 09; 30(8):731-7. PubMed ID: 413842
    [Abstract] [Full Text] [Related]

  • 38. Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolates.
    Price KE, DeFuria MD, Pursiano TA.
    J Infect Dis; 1976 Nov 09; 134 SUPPL():S249-61. PubMed ID: 62814
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of Pseudomonas aeruginosa keratitis with tobramycin and gentamicin: animal experiments (author's transl)].
    Behrens-Baumann W, Paul HH, Ansorg R.
    Klin Monbl Augenheilkd; 1981 Mar 09; 178(3):197-9. PubMed ID: 7230715
    [Abstract] [Full Text] [Related]

  • 40. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB, Penner JL.
    Can Med Assoc J; 1975 Jul 12; 113(1):29-31. PubMed ID: 807310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.